211 related articles for article (PubMed ID: 19009564)
1. Resident hepatocyte fibroblast growth factor receptor 4 limits hepatocarcinogenesis.
Huang X; Yang C; Jin C; Luo Y; Wang F; McKeehan WL
Mol Carcinog; 2009 Jun; 48(6):553-62. PubMed ID: 19009564
[TBL] [Abstract][Full Text] [Related]
2. Ectopic activity of fibroblast growth factor receptor 1 in hepatocytes accelerates hepatocarcinogenesis by driving proliferation and vascular endothelial growth factor-induced angiogenesis.
Huang X; Yu C; Jin C; Kobayashi M; Bowles CA; Wang F; McKeehan WL
Cancer Res; 2006 Feb; 66(3):1481-90. PubMed ID: 16452204
[TBL] [Abstract][Full Text] [Related]
3. Forced expression of hepatocyte-specific fibroblast growth factor 21 delays initiation of chemically induced hepatocarcinogenesis.
Huang X; Yu C; Jin C; Yang C; Xie R; Cao D; Wang F; McKeehan WL
Mol Carcinog; 2006 Dec; 45(12):934-42. PubMed ID: 16929488
[TBL] [Abstract][Full Text] [Related]
4. Metabolic regulator betaKlotho interacts with fibroblast growth factor receptor 4 (FGFR4) to induce apoptosis and inhibit tumor cell proliferation.
Luo Y; Yang C; Lu W; Xie R; Jin C; Huang P; Wang F; McKeehan WL
J Biol Chem; 2010 Sep; 285(39):30069-78. PubMed ID: 20657013
[TBL] [Abstract][Full Text] [Related]
5. Independent repression of bile acid synthesis and activation of c-Jun N-terminal kinase (JNK) by activated hepatocyte fibroblast growth factor receptor 4 (FGFR4) and bile acids.
Yu C; Wang F; Jin C; Huang X; McKeehan WL
J Biol Chem; 2005 May; 280(18):17707-14. PubMed ID: 15750181
[TBL] [Abstract][Full Text] [Related]
6. Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice.
Padrissa-Altés S; Bachofner M; Bogorad RL; Pohlmeier L; Rossolini T; Böhm F; Liebisch G; Hellerbrand C; Koteliansky V; Speicher T; Werner S
Gut; 2015 Sep; 64(9):1444-53. PubMed ID: 25416068
[TBL] [Abstract][Full Text] [Related]
7. FGFR4 prevents hyperlipidemia and insulin resistance but underlies high-fat diet induced fatty liver.
Huang X; Yang C; Luo Y; Jin C; Wang F; McKeehan WL
Diabetes; 2007 Oct; 56(10):2501-10. PubMed ID: 17664243
[TBL] [Abstract][Full Text] [Related]
8. Compound deletion of Fgfr3 and Fgfr4 partially rescues the Hyp mouse phenotype.
Li H; Martin A; David V; Quarles LD
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E508-17. PubMed ID: 21139072
[TBL] [Abstract][Full Text] [Related]
9. Differential distribution of fibroblast growth factor receptors (FGFRs) on foveal cones: FGFR-4 is an early marker of cone photoreceptors.
Cornish EE; Natoli RC; Hendrickson A; Provis JM
Mol Vis; 2004 Jan; 10():1-14. PubMed ID: 14737068
[TBL] [Abstract][Full Text] [Related]
10. Differential specificity of endocrine FGF19 and FGF21 to FGFR1 and FGFR4 in complex with KLB.
Yang C; Jin C; Li X; Wang F; McKeehan WL; Luo Y
PLoS One; 2012; 7(3):e33870. PubMed ID: 22442730
[TBL] [Abstract][Full Text] [Related]
11. The ileal FGF15/19 to hepatic FGFR4 axis regulates liver regeneration after partial hepatectomy in mice.
Li Q; Zhao Q; Zhang C; Zhang P; Hu A; Zhang L; Schroder PM; Ma Y; Guo Z; Zhu X; He X
J Physiol Biochem; 2018 May; 74(2):247-260. PubMed ID: 29468415
[TBL] [Abstract][Full Text] [Related]
12. Increased carbon tetrachloride-induced liver injury and fibrosis in FGFR4-deficient mice.
Yu C; Wang F; Jin C; Wu X; Chan WK; McKeehan WL
Am J Pathol; 2002 Dec; 161(6):2003-10. PubMed ID: 12466116
[TBL] [Abstract][Full Text] [Related]
13. FGF19-induced hepatocyte proliferation is mediated through FGFR4 activation.
Wu X; Ge H; Lemon B; Vonderfecht S; Weiszmann J; Hecht R; Gupte J; Hager T; Wang Z; Lindberg R; Li Y
J Biol Chem; 2010 Feb; 285(8):5165-70. PubMed ID: 20018895
[TBL] [Abstract][Full Text] [Related]
14. Hepatocyte FRS2α is essential for the endocrine fibroblast growth factor to limit the amplitude of bile acid production induced by prandial activity.
Wang C; Yang C; Chang JY; You P; Li Y; Jin C; Luo Y; Li X; McKeehan WL; Wang F
Curr Mol Med; 2014; 14(6):703-711. PubMed ID: 25056539
[TBL] [Abstract][Full Text] [Related]
15. FGFR1 and FGFR4 oncogenicity depends on n-cadherin and their co-expression may predict FGFR-targeted therapy efficacy.
Quintanal-Villalonga Á; Ferrer I; Guruceaga E; Cirauqui C; Marrugal Á; Ojeda L; García S; Zugazagoitia J; Muñoz-Galván S; Lopez-Rios F; Montuenga L; Vicent S; Molina-Pinelo S; Carnero A; Paz-Ares L
EBioMedicine; 2020 Mar; 53():102683. PubMed ID: 32114392
[TBL] [Abstract][Full Text] [Related]
16. Skeletal muscle satellite cell proliferation in response to members of the fibroblast growth factor family and hepatocyte growth factor.
Sheehan SM; Allen RE
J Cell Physiol; 1999 Dec; 181(3):499-506. PubMed ID: 10528236
[TBL] [Abstract][Full Text] [Related]
17. FGF19 regulates cell proliferation, glucose and bile acid metabolism via FGFR4-dependent and independent pathways.
Wu AL; Coulter S; Liddle C; Wong A; Eastham-Anderson J; French DM; Peterson AS; Sonoda J
PLoS One; 2011 Mar; 6(3):e17868. PubMed ID: 21437243
[TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor receptors display both common and distinct signaling pathways.
Shaoul E; Reich-Slotky R; Berman B; Ron D
Oncogene; 1995 Apr; 10(8):1553-61. PubMed ID: 7731710
[TBL] [Abstract][Full Text] [Related]
19. Elevated cholesterol metabolism and bile acid synthesis in mice lacking membrane tyrosine kinase receptor FGFR4.
Yu C; Wang F; Kan M; Jin C; Jones RB; Weinstein M; Deng CX; McKeehan WL
J Biol Chem; 2000 May; 275(20):15482-9. PubMed ID: 10809780
[TBL] [Abstract][Full Text] [Related]
20. Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver.
Cui G; Martin RC; Jin H; Liu X; Pandit H; Zhao H; Cai L; Zhang P; Li W; Li Y
J Exp Clin Cancer Res; 2018 Jul; 37(1):136. PubMed ID: 29973237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]